Global Cardiopulmonary Autotransfusion System Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Cardiopulmonary Autotransfusion System market size will reach 637.50 Million USD in 2025 and is projected to reach 749.55 Million USD by 2032, with a CAGR of 2.34% (2025-2032). Notably, the China Cardiopulmonary Autotransfusion System market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
A cardiopulmonary autotransfusion system, also known as a cell saver or intraoperative blood salvage system, is a medical device used during surgical procedures to collect and process a patient＇s own blood for reinfusion. The system works by capturing and filtering blood lost during surgery, such as from the operative field or during cardiopulmonary bypass, and returning it back to the patient. The collected blood is processed to remove any contaminants, including debris and anticoagulants, and then reinfused to replenish the patient＇s blood volume. By utilizing the patient＇s own blood, cardiopulmonary autotransfusion reduces or eliminates the need for donor blood transfusions, minimizing the risks associated with transfusion reactions and transmission of infections. It is commonly used in cardiac surgery, orthopedic procedures, and other surgeries where significant blood loss is anticipated. Cardiopulmonary autotransfusion systems contribute to improved patient outcomes, reduced need for allogeneic blood transfusions, and cost savings in the healthcare setting.
The major global manufacturers of Cardiopulmonary Autotransfusion System include Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Cardiopulmonary Autotransfusion System. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Cardiopulmonary Autotransfusion System market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Cardiopulmonary Autotransfusion System market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Cardiopulmonary Autotransfusion System industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Cardiopulmonary Autotransfusion System Include:
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
Cardiopulmonary Autotransfusion System Product Segment Include:
Intraoperative Autotransfusion Systems
Postoperative Autotransfusion Systems
Cardiopulmonary Autotransfusion System Product Application Include:
Cardiac Surgeries
Orthopedic Surgeries
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Cardiopulmonary Autotransfusion System Industry PESTEL Analysis
Chapter 3: Global Cardiopulmonary Autotransfusion System Industry Porter's Five Forces Analysis
Chapter 4: Global Cardiopulmonary Autotransfusion System Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Cardiopulmonary Autotransfusion System Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Cardiopulmonary Autotransfusion System Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Cardiopulmonary Autotransfusion System market size will reach 637.50 Million USD in 2025 and is projected to reach 749.55 Million USD by 2032, with a CAGR of 2.34% (2025-2032). Notably, the China Cardiopulmonary Autotransfusion System market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
A cardiopulmonary autotransfusion system, also known as a cell saver or intraoperative blood salvage system, is a medical device used during surgical procedures to collect and process a patient＇s own blood for reinfusion. The system works by capturing and filtering blood lost during surgery, such as from the operative field or during cardiopulmonary bypass, and returning it back to the patient. The collected blood is processed to remove any contaminants, including debris and anticoagulants, and then reinfused to replenish the patient＇s blood volume. By utilizing the patient＇s own blood, cardiopulmonary autotransfusion reduces or eliminates the need for donor blood transfusions, minimizing the risks associated with transfusion reactions and transmission of infections. It is commonly used in cardiac surgery, orthopedic procedures, and other surgeries where significant blood loss is anticipated. Cardiopulmonary autotransfusion systems contribute to improved patient outcomes, reduced need for allogeneic blood transfusions, and cost savings in the healthcare setting.
The major global manufacturers of Cardiopulmonary Autotransfusion System include Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Cardiopulmonary Autotransfusion System. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Cardiopulmonary Autotransfusion System market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Cardiopulmonary Autotransfusion System market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Cardiopulmonary Autotransfusion System industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Cardiopulmonary Autotransfusion System Include:
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
Cardiopulmonary Autotransfusion System Product Segment Include:
Intraoperative Autotransfusion Systems
Postoperative Autotransfusion Systems
Cardiopulmonary Autotransfusion System Product Application Include:
Cardiac Surgeries
Orthopedic Surgeries
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Cardiopulmonary Autotransfusion System Industry PESTEL Analysis
Chapter 3: Global Cardiopulmonary Autotransfusion System Industry Porter's Five Forces Analysis
Chapter 4: Global Cardiopulmonary Autotransfusion System Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Cardiopulmonary Autotransfusion System Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Cardiopulmonary Autotransfusion System Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Cardiopulmonary Autotransfusion System Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Cardiopulmonary Autotransfusion System Product by Type
- 1.2.1 Intraoperative Autotransfusion Systems
- 1.2.2 Postoperative Autotransfusion Systems
- 1.3 Cardiopulmonary Autotransfusion System Product by Application
- 1.3.1 Cardiac Surgeries
- 1.3.2 Orthopedic Surgeries
- 1.3.3 Other
- 1.4 Global Cardiopulmonary Autotransfusion System Market Revenue and Sales Analysis
- 1.4.1 Global Cardiopulmonary Autotransfusion System Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Cardiopulmonary Autotransfusion System Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Cardiopulmonary Autotransfusion System Market Sales Price Trend Analysis (2020-2032)
- 1.5 Cardiopulmonary Autotransfusion System Market Development Status and Trends
- 1.5.1 Cardiopulmonary Autotransfusion System Industry Development Status Analysis
- 1.5.2 Cardiopulmonary Autotransfusion System Industry Development Trends Analysis
- 2 Cardiopulmonary Autotransfusion System Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Cardiopulmonary Autotransfusion System Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Cardiopulmonary Autotransfusion System Market Analysis by Country
- 4.1 Global Cardiopulmonary Autotransfusion System Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Cardiopulmonary Autotransfusion System Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Cardiopulmonary Autotransfusion System Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Cardiopulmonary Autotransfusion System Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Cardiopulmonary Autotransfusion System Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Cardiopulmonary Autotransfusion System Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Cardiopulmonary Autotransfusion System Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Cardiopulmonary Autotransfusion System Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Cardiopulmonary Autotransfusion System Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Cardiopulmonary Autotransfusion System Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Cardiopulmonary Autotransfusion System Average Sales Price by Manufacturers (2021-2025)
- 5.2 Cardiopulmonary Autotransfusion System Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Cardiopulmonary Autotransfusion System Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Cardiopulmonary Autotransfusion System Market Analysis by Type
- 6.1 Global Cardiopulmonary Autotransfusion System Market Revenue Analysis by Type
- 6.1.1 Global Cardiopulmonary Autotransfusion System Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Cardiopulmonary Autotransfusion System Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Cardiopulmonary Autotransfusion System Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Cardiopulmonary Autotransfusion System Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Haemonetics
- 7.1.1 Haemonetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Haemonetics Cardiopulmonary Autotransfusion System Product Portfolio
- 7.1.3 Haemonetics Cardiopulmonary Autotransfusion System Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Medtronic
- 7.2.1 Medtronic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Medtronic Cardiopulmonary Autotransfusion System Product Portfolio
- 7.2.3 Medtronic Cardiopulmonary Autotransfusion System Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 LivaNova
- 7.3.1 LivaNova Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 LivaNova Cardiopulmonary Autotransfusion System Product Portfolio
- 7.3.3 LivaNova Cardiopulmonary Autotransfusion System Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Fresenius Kabi
- 7.4.1 Fresenius Kabi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Fresenius Kabi Cardiopulmonary Autotransfusion System Product Portfolio
- 7.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Terumo
- 7.5.1 Terumo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Terumo Cardiopulmonary Autotransfusion System Product Portfolio
- 7.5.3 Terumo Cardiopulmonary Autotransfusion System Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Wandong Health Sources
- 7.6.1 Wandong Health Sources Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Wandong Health Sources Cardiopulmonary Autotransfusion System Product Portfolio
- 7.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Cardiopulmonary Autotransfusion System Industry Chain Analysis
- 8.2 Cardiopulmonary Autotransfusion System Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers an
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
